Clinical Trial: Harm Reduction Intervention for People Who Use Anabolic Androgenic Steroids: the Randomized Controlled Trial

U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07039539) titled 'Harm Reduction Intervention for People Who Use Anabolic Androgenic Steroids: the Randomized Controlled Trial' on June 18.

Brief Summary: This study is about harm reduction (HR) practices for peolple who use anabolic androgenic steroids. It is a randomized controlled trial (RCT) that will compare a group that will receive an intervention in HR and another control (CTRL) that will receive usual guidelines. The primary outcome is the reduction in the final amount of drug consumed in relation to the initial planned amount. The secondary outcome is the understanding of what made the participants change their beliefs and change the planne...